CONTRAVIR PHARMACEUTICALS IN's ticker is CTRVXXXX and the CUSIP is 21234W103. A total of 1 filers reported holding CONTRAVIR PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $15,000 | -42.3% | 67,019 | -6.7% | 0.00% | – |
| Q4 2017 | $26,000 | -29.7% | 71,818 | -0.7% | 0.00% | – |
| Q3 2017 | $37,000 | -78.5% | 72,346 | -75.8% | 0.00% | – |
| Q2 2017 | $172,000 | -82.6% | 298,878 | -46.4% | 0.00% | – |
| Q1 2017 | $986,000 | +48.0% | 557,596 | +0.4% | 0.00% | – |
| Q4 2016 | $666,000 | +166.4% | 555,358 | +137.8% | 0.00% | – |
| Q3 2016 | $250,000 | +0.4% | 233,580 | -2.5% | 0.00% | – |
| Q2 2016 | $249,000 | -18.1% | 239,450 | -5.1% | 0.00% | – |
| Q1 2016 | $304,000 | -22.4% | 252,313 | -1.1% | 0.00% | – |
| Q4 2015 | $392,000 | -0.3% | 255,022 | +35.7% | 0.00% | – |
| Q3 2015 | $393,000 | -44.5% | 187,942 | +34.8% | 0.00% | – |
| Q2 2015 | $708,000 | +155.6% | 139,379 | +54.7% | 0.00% | – |
| Q1 2015 | $277,000 | – | 90,073 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EAM Investors, LLC | 670,593 | $3,401,000 | 0.45% |
| Prospera Financial Services Inc | 184,100 | $236,000 | 0.05% |
| HighTower Advisors, LLC | 1,047,731 | $1,257,000 | 0.01% |
| TWO SIGMA SECURITIES, LLC | 15,142 | $18,000 | 0.01% |
| TEACHERS ADVISORS, LLC | 298,781 | $1,820,000 | 0.00% |
| TIAA CREF INVESTMENT MANAGEMENT LLC | 724,455 | $4,412,000 | 0.00% |
| Virtu KCG Holdings LLC | 90,490 | $109,000 | 0.00% |
| FIRST FOUNDATION ADVISORS | 10,000 | $12,000 | 0.00% |
| Acrospire Investment Management LLC | 2,300 | $3,000 | 0.00% |
| Balentine LLC | 55 | $0 | 0.00% |